Firefly Neuroscience, Inc.
AIFF
$1.73
$0.052.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -173.31% | -455.24% | -600.69% | -301.84% | -217.31% |
| Total Depreciation and Amortization | 687.50% | 575.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 399.63% | 5,671.59% | 5,230.00% | 1,185.76% | 930.42% |
| Change in Net Operating Assets | 66.34% | -708.90% | 75.28% | 227.21% | -725.76% |
| Cash from Operations | -39.65% | -136.40% | -125.51% | -183.38% | -157.66% |
| Capital Expenditure | -172.06% | -60.94% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.56% | 87.22% | 61.70% | 14.77% | -- |
| Cash from Investing | -222.87% | -264.47% | 31.72% | -23.58% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 37.12% | 269.78% | 212.39% | 13.91% | 2,232.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 50.79% | -35.72% | -54.86% | -60.03% | -60.03% |
| Repurchase of Preferred Stock | 28.38% | -40.23% | 20.05% | 20.05% | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 101.54% | 283.73% | 193.81% | 35.67% | 139.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 818.40% | 50,445.45% | 414.44% | -115.97% | -46.25% |